| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |